본문으로 건너뛰기
← 뒤로

Oncogenic function and transcriptional dynamics of MYCN in liver tumorigenesis.

1/5 보강
Proceedings of the National Academy of Sciences of the United States of America 📖 저널 OA 99.2% 2022: 2/2 OA 2023: 1/1 OA 2024: 8/8 OA 2025: 44/44 OA 2026: 57/58 OA 2022~2026 2026 Vol.123(8) p. e2521923123
Retraction 확인
출처

Qin XY, Xu Y, Mishra H, Shirakami Y, Yeh SH, Li CL, Numata K, Suenaga Y, Wei F, Ando R, Nishimura H, Furuhata E, Maeda S, Furutani Y, Yanaka K, Yamamoto M, Goto M, Takasawa A, Nishikawa Y, Tomita H, Gailhouste L, Matsuura T, Chen PJ, Shimizu M, Hippo Y, Suzuki H

📝 환자 설명용 한 줄

Hepatocellular carcinoma (HCC) is a leading cause of cancer-related mortality.

이 논문을 인용하기

↓ .bib ↓ .ris
APA Qin XY, Xu Y, et al. (2026). Oncogenic function and transcriptional dynamics of MYCN in liver tumorigenesis.. Proceedings of the National Academy of Sciences of the United States of America, 123(8), e2521923123. https://doi.org/10.1073/pnas.2521923123
MLA Qin XY, et al.. "Oncogenic function and transcriptional dynamics of MYCN in liver tumorigenesis.." Proceedings of the National Academy of Sciences of the United States of America, vol. 123, no. 8, 2026, pp. e2521923123.
PMID 41706888 ↗

Abstract

Hepatocellular carcinoma (HCC) is a leading cause of cancer-related mortality. It is often diagnosed at advanced stages and characterized by high recurrence rates. Although chronic liver inflammation and metabolic dysfunction are established contributors to tumorigenesis, the molecular mechanisms that link microenvironmental stress to malignant transformation remain poorly understood. MYCN, a proto-oncogenic transcription factor, has emerged as a potential biomarker of cancer stemness. However, its role in hepatocarcinogenesis remains unclear. In this study, we elucidated the oncogenic role of MYCN and its dynamic transcriptional regulation during liver tumorigenesis. Using a hydrodynamic tail vein injection-based transposon system in mice, we demonstrated that MYCN overexpression synergizes with AKT activation to promote liver tumorigenesis. Transcriptomic profiling revealed that MYCN-driven tumors exhibited features of human HCC subtypes enriched in stress-adaptive transcriptional programs. Time-resolved spatial transcriptomics further uncovered a MYCN-enriched niche characterized by epithelial-mesenchymal transition (EMT) and Wnt/β-catenin signaling, which expanded during tumor progression and was spatially proximate to transformed malignant cells. To translate these findings to human HCC, we developed a machine learning-based MYCN niche score and validated its clinical relevance across multiple human HCC cohorts. This score reliably predicted recurrence risk and identified EMT-prone microenvironments, with stronger predictive performance in nontumor tissues, suggesting its potential in detecting precancerous niches predisposed to de novo tumorigenesis. Collectively, our findings establish MYCN as a functional driver and spatial marker of tumor-promoting microenvironments in liver tumorigenesis; additionally, we propose a clinically actionable strategy to identify high-risk patients through transcriptomic profiling of nontumor liver tissue.

🏷️ 키워드 / MeSH 📖 같은 키워드 OA만

🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반

🟢 PMC 전문 열기